Ophthalmology Introduction

Table of Contents How Is Eligibility for Vyznova Determined? Examinations to Prepare for Your Remote Consultation Clinical History and Basic Information Anterior Segment Imaging (Corneal Examinations) Posterior Segment Imaging (Retina and Optic Nerve Examinations) Who Is a Good Candidate for Vyznova? To determine whether Vyznova (neltependocel) treatment may be right for you, we need to carefully evaluate the current condition of your eye. Not every patient with bullous ker

If your vision has been slowly clouding and you have been told that a corneal transplant may be your only option, you are not alone, and you may have more choices than you realize. Access Vyznova (neltependocel) exclusively at Japan's leading specialized corneal centers. As your trusted gateway, we provide precise information to help you select a medical institution and corneal specialist well-suited to your unique needs, calmly and without pressure. From arranging direct onl

"Ophthoagent" is a service that connects patients worldwide with Japanese ophthalmologists, offering expert information and consultation grounded in my insight as a practicing ophthalmologist. “Freeing patients from the burden of choice when seeking a specialist.” “Smoothly reaching the specialist who is best suited for you.” At Vision Forth Inc., our goal is to provide patients with a future defined by these two ideals. We want to eliminate the uncertainty for those who worr

<Profile> Shigeto Shimmura, MD, PhD Professor and Chair, Department of Clinical Regenerative Medicine, Fujita Health University Spent his youth in Montreal, Canada, before entering the Keio University School of Medicine in 1983. Since graduating in 1989, he has specialized in ophthalmology and regenerative medicine. As a leading cornea specialist, Dr. Shimmura has performed over 1,000 corneal transplants and more than 100 corneal regenerative medicine surgeries. He has also c

1.Introduction Japan has established itself as a global leader for advanced ophthalmic regenerative medicine, offering new possibilities for restoring vision previously considered untreatable. As patients worldwide seek reliable medical solutions, ophthalmic care in Japan has progressed from slowing disease progression to actively regenerating visual function. Supported by a strict yet proactive regulatory framework for regenerative therapeutics, Japan has achieved multiple w

1.Introduction: The Standard of Visual Precision For global executives and individuals who prioritize Quality of Life (QOL), the criteria for choosing ophthalmic care have shifted. It is no longer just about treating a disease, but about securing a high quality of post-operative vision—specifically, the restoration of precise contrast and achieving the target refraction. In 2026, Japan is increasingly recognized as an attractive destination for medical tourism, due in part to

If you or a family member is scheduled for Vyznova corneal endothelial cell injection therapy, knowing what happens on surgery day — from the moment you arrive to the critical three-hour face-down positioning period — can transform anxiety into confidence. This guide provides a comprehensive, clinically grounded walkthrough of the entire procedure, explains the rationale behind prone positioning, and answers the questions patients ask most. By the end, you will understand not

International patients seeking Vyznova corneal endothelial cell therapy in Japan need a clear roadmap. This guide provides step-by-step instructions for finding candidate hospitals, securing medical visas, budgeting total costs, and planning your treatment itinerary from initial consultation to post-operative follow-up. Table of Contents Why Japan for Vyznova Corneal Regenerative Treatment? Finding Vyznova Partner Hospitals in Japan Understanding Medical Visa Requirements for

1. Why Japan is the Global Gold Standard for Eye Care Ophthalmology is a field of modern medicine that demands an extraordinary level of delicacy and precision. In the pursuit of preserving visual function, Japan has established a global reputation for excellence through consistent clinical standards and superior technical expertise. The high success rate of treatment in Japan is driven by a unique synergy: the fusion of refined surgical skill and advanced medical technology.

Table of Contents What is Bullous Keratopathy? Disease Burden and Treatment Limitations What is Vyznova (Neltependocel)? Mechanism of Action and Product Overview Japanese Clinical Data Facilitating PMDA Approval Experience to Date: Post-Launch Real-World Outcomes Cell Therapy vs Standard Corneal Transplant: Clinical Advantages of Vyznova Regulatory Status and Global Development Outlook Industry and Market Impact Conclusion: A New Paradigm in Corneal Endothelial Disease Manage

Table of Contents Clinical Introduction and Therapeutic Modality of Vyznova (Neltependocel) The Financial Framework of Vyznova (Neltependocel) Cost in Japan Financial Landscape and Value Justification Conclusion Clinical Introduction and Therapeutic Modality of Vyznova (Neltependocel) Neltependocel (marketed under the brand name Vyznova) represents a first-in-class regenerative cell therapy indicated for the treatment of corneal endothelial dysfunction, specifically bullous k

Summary For patients interested in laser refractive surgery for vision correction. Japan offers a highly reliable choice, based on advanced surgical expertise and a conservative medical culture that ensures patient safety and refractive precision. Please contact us to determine your eligibility for this therapy. I. Introduction Laser refractive surgery is a specialized surgical procedure aimed at correcting refractive errors—myopia, hyperopia, and astigmatism—by permanently a

I. Introduction: The Evolution of Presbyopia-Correcting IOLs For years, patients undergoing cataract surgery had to choose between monofocal lenses (excellent clarity but limited range) and traditional multifocal lenses (great range but prone to glare and halos). The introduction of the AcrySof™ IQ Vivity™ IOL has revolutionized the landscape. As the world's first non-diffractive Extended Depth of Focus (EDOF) lens, Vivity offers a continuous range of vision with a visual p

I. Introduction: Is vitreous hemorrhage curable ? The most pressing question for anyone experiencing a sudden blackout or "cloud" in their vision is: "Is vitreous hemorrhage curable ?" The short answer is yes —in the vast majority of cases, the blood can be cleared, and functional vision can be restored. However, "curable" in the context of eye health means two things: clearing the existing blood and treating the underlying disease that caused the leak. This article explores

I. Introduction: Understanding the Duration (Surgery Time) of Vitrectomy for Vitreous Hemorrhage When facing vitreous hemorrhage surgery (Pars Plana Vitrectomy), one of the most common questions patients ask is: "How long will I be in the operating room?" Because this is a delicate microsurgical procedure performed under a microscope, the time required can vary based on the complexity of the underlying retinal condition. Generally, modern surgical techniques have made this

I. Introduction: What to Expect After Surgery for Vitreous Hemorrhage, Recovery Course The success of vitreous hemorrhage surgery recovery depends as much on the post-operative care as it does on the surgery itself. While the removal of blood (vitrectomy) provides a clear path for light to reach the retina, the eye needs time to heal from the microscopic incisions and the internal manipulation of retinal tissues. Understanding the typical recovery course—including vision ch

I. Introduction: When is Surgery Necessary for a Bleeding Eye? While many minor eye bleeds resolve on their own, vitreous hemorrhage surgery is a life-changing intervention for patients with dense or persistent bleeding. Known medically as a Pars Plana Vitrectomy (PPV) , this advanced microsurgical procedure involves removing the blood-stained vitreous gel and replacing it with a clear substitute. For patients whose vision has been "blacked out" by a hemorrhage, this surger

I. Introduction: What is Vitreous Hemorrhage Treatment? A sudden "cloud" or "shower of floaters" in your vision can be a frightening experience. However, the good news is that vitreous hemorrhage treatment has evolved significantly, offering excellent outcomes for the majority of patients. The approach to treating a bleed inside the eye is highly strategic. It ranges from conservative "wait-and-see" observation to advanced microsurgery, depending entirely on the underlying

I. Introduction: The Diagnosis Challenge of Vitreous Hemorrhage When blood leaks into the vitreous cavity, it creates a physical barrier for both the patient and the physician. For the patient, vision becomes clouded; for the doctor, the view of the retina—the most critical part of the eye—is obstructed. Accurate vitreous hemorrhage diagnosis is not merely about confirming the presence of blood. Its primary goal is to evaluate the underlying retinal anatomy to rule out life

I. Introduction: What is Vitreous Hemorrhage Causes In a healthy state, the blood vessels within the eye are robust and contained. However, certain diseases and injuries can cause these vessels to rupture, leading to a vitreous hemorrhage . Understanding vitreous hemorrhage causes is vital because the treatment for a bleed caused by diabetes differs significantly from a bleed caused by a physical injury or a retinal tear. Generally, the causes of vitreous hemorrhage fall int